2026

英文原著

  1. 1.

    Eto E, et al. Improved prognosis prediction of all-cause mortality and cardiovascular events by combined assessment of both Ankle-Brachial Index and brachial-ankle Pulse Wave Velocity in individuals with diabetes: the Kyushu Prevention Study for Atherosclerosis, a prospective, multicenter survey. J Diabetes Investig in press

  2. 2.

    Hashimoto K, et al. Effects of External Radiation Dose on Pediatric Peripheral Blood Components After the Great East Japan Earthquake: Fukushima Health Management Survey. Sci Rep in press pubmed

  3. 3.

    Hayashi F, et al. Association between steatotic liver disease and post-traumatic stress symptoms in the Fukushima Health Management Survey. Sci Rep in press pubmed

  4. 4.

    Kazama S, Hayashi F, Tanaka K, Sato S, Ueda Y, Okazaki K, Ohira T, Sakai A, Maeda M, Yabe H, Hosoya M, Takahashi A, Nakano H, Nagao M, Shimabukuro M, Ohto H, Yasumura S, Kazama JJ. Association of Severe Stress with the Onset of Chronic Kidney Disease after the Great East Japan Earthquake: The Fukushima Health Management Survey. Clin Exp Nephrol in press pubmed

  5. 5.

    Ma E, Ohira T, Fukasawa M, Shirafuji A, Ohira H, Shimabukuro M. Trends in heart failure prevalence in post-disaster Fukushima residents 2015–2021. Sci Rep 2026;16:5222. pubmed

  6. 6.
    Oda A, et al. eGFR Slope and Risk of Cardiovascular, Kidney, and Mortality Outcomes in Hypertension: A Longitudinal Cohort Study. J Hypertens in press
  7. 7.
    Okamoto S, et al. γ-Oryzanol, a unique ingredient specific to brown rice, effectively restores mild cognitive impairment (MCI) in obese aged mice by ameliorating microglial inflammation and promoting neurogenesis in hippocampus: Novel therapeutic insight into obesity-associated MCI. J Food Bioactives in press
  8. 8.

    Sakai A, et al. Changes in peripheral blood test results among adults in the six years following the Great East Japan Earthquake: the Fukushima Health Management Survey. Fukushima J Med Sci in press pubmed

  9. 9.

    Tanabe H, Kono T, Saito H, Maimaituxun G, Tanaka K, Kazama JJ, Shimabukuro M. Peri-renal and sinus fat accumulation and diabetic kidney disease in type 2 diabetes: A Japanese cohort study. Diabetes Res Clin Pract 2026:232:113074. pubmed

  10. 10.

    Tanabe H, Shimajiri Y, Shiroma K, Higa M, Masuzaki H, Shimabukuro M. Unequal distribution of plasma glucagon levels among clustering-based diabetes subtypes: a Japanese cohort. J Clin Endocrinol Metab in press pubmed

  11. 11.

    Watanabe G, Horita S, Moriya RF, Masuishi Y, Misaka S, Taira S, Shimomura K, Shimabukuro M, Kazama JJ. Canagliflozin-Induced renal glutathione distribution mapping in non-diabetic male rat kidneys. Physiol Rep in press pubmed

  12. 12.

    Watanabe-Shimoji K, Tanabe H, Ohsugi M, Kawakami E, Tanaka K, Kazama JJ, Ueki K, and Shimabukuro M for the J-DREAMS Investigators. Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS Registry. Diabetologia in press pubmed

  13. 13.

    Watanabe S, Tanaka K, Kimura H, Saito H, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association between mean platelet volume and kidney events in patients with type 2 diabetes mellitus. J Diabetes Investig 2026;17:51–9. pubmed

英文総説

  1. 1.Shimabukuro M, Tanabe H, Nomura K, Matsuo M, Sakaue H. Response to comment on Tanabe et al. Prediction of sarcopenia onset in type 2 diabetes using urinary titin levels: a Japanese prospective cohort study. Diabetes Care 2026;49:e6. pubmed

英文症例

和文著書

和文総説

ページの先頭へ戻る